Skip to main content
Clinical Trials/JPRN-UMIN000051441
JPRN-UMIN000051441
Completed
未知

A verification study of the test product of skin improvement effect by application of test product: an open-label study - A verification study of the test product of skin improvement effect by application of test product

Wayo Women's University0 sites17 target enrollmentJune 23, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy Japanese subjects
Sponsor
Wayo Women's University
Enrollment
17
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 23, 2023
End Date
July 10, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Wayo Women's University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2\. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3\. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4\. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" in daily 5\. Subjects who are currently taking medications (including herbal medicines) and supplements 6\. Subjects who are allergic to medicines and/or the test product related products 7\. Subjects who have a medical history of allergy due to using cosmetics 8\. Subjects who have inflammation symptoms at the site of application (elbow, knee, or heel) 9\. Subjects who use skincare products on the site of application (elbow, knee, or heel) or receive skincare treatment during this trial 10\. Subjects who are pregnant, lactating, or planning to become pregnant during this trial 11\. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 12\. Subjects who are judged as ineligible to participate in this study by the physician

Outcomes

Primary Outcomes

Not specified

Similar Trials